Literature DB >> 27329229

Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis.

Luisa Senra1, Romaine Stalder1, David Alvarez Martinez2, Carlo Chizzolini3, Wolf-Henning Boehncke4, Nicolò Costantino Brembilla1.   

Abstract

Psoriasis is a chronic inflammatory skin disorder effectively treated by blocking IL-17RA, a receptor chain used by several IL-17 family members, including IL-17E. Although IL-17A is critically involved in the pathogenesis of psoriasis, the contribution of IL-17E remains unknown. Here we show that IL-17E(+) cells are more abundant than IL-17A(+) cells in lesional psoriatic skin. IL-17E synthesis is increased in keratinocytes within psoriatic plaques, and macrophages having a mixed M1/M2 phenotype represent an important proportion of the IL-17E(+) cells infiltrating the dermis. Mechanistically, macrophages do not synthetize but rather take up IL-17E via receptor-mediated clathrin-dependent endocytosis. Furthermore, monocyte-derived macrophages in vitro polarized in M2, but not M1, express the IL-17E receptor and respond to IL-17E by preferentially producing inflammatory cytokines and chemokines involved in neutrophil recruitment. Remarkably, IL-17E expression in lesional psoriatic skin correlates with the number of neutrophils while being inversely proportional to the number of infiltrating T cells. These data provide strong evidence for a proinflammatory role of keratinocyte-derived IL-17E in psoriasis, possibly via macrophage activation.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27329229     DOI: 10.1016/j.jid.2016.06.009

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

1.  The elegance of a macrophage.

Authors:  Maria De Santis; Massimo Locati; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2017-07-31       Impact factor: 11.530

Review 2.  Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.

Authors:  Wolf-Henning Boehncke; Nicolo Costantino Brembilla
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

3.  Interleukin (IL)-17A and IL-22-producing neutrophils in psoriatic skin.

Authors:  B Dyring-Andersen; T V Honoré; A Madelung; M Bzorek; S Simonsen; S N Clemmensen; R A Clark; N Borregaard; L Skov
Journal:  Br J Dermatol       Date:  2017-10-08       Impact factor: 9.302

Review 4.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

Review 5.  The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis.

Authors:  G Girolomoni; R Strohal; L Puig; H Bachelez; J Barker; W H Boehncke; J C Prinz
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-08-29       Impact factor: 6.166

Review 6.  The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond.

Authors:  Nicolo Costantino Brembilla; Luisa Senra; Wolf-Henning Boehncke
Journal:  Front Immunol       Date:  2018-08-02       Impact factor: 7.561

Review 7.  Role of Neutrophils in Psoriasis.

Authors:  Wen-Ming Wang; Hong-Zhong Jin
Journal:  J Immunol Res       Date:  2020-06-05       Impact factor: 4.818

Review 8.  From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment.

Authors:  Silvia Vidal; Lluís Puig; José-Manuel Carrascosa-Carrillo; Álvaro González-Cantero; José-Carlos Ruiz-Carrascosa; Antonio-Manuel Velasco-Pastor
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 9.  Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis.

Authors:  Lipeng Tang; Xiaozhi Yang; Yongxin Liang; Hesong Xie; Zhenhua Dai; Guangjuan Zheng
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

Review 10.  Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.

Authors:  Dominik Samotij; Bogusław Nedoszytko; Joanna Bartosińska; Aleksandra Batycka-Baran; Rafał Czajkowski; Iwona T Dobrucki; Lawrence W Dobrucki; Magdalena Górecka-Sokołowska; Anna Janaszak-Jasienicka; Dorota Krasowska; Leszek Kalinowski; Marta Macieja-Stawczyk; Roman J Nowicki; Agnieszka Owczarczyk-Saczonek; Agata Płoska; Dorota Purzycka-Bohdan; Adrianna Radulska; Edyta Reszka; Anna Siekierzycka; Andrzej Słomiński; Radomir Słomiński; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz; Justyna Szczęch; Michał Żmijewski; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2020-05-05       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.